Skip to content

Author

Lakshmanane Premkumar

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

A single dose of Dengvaxia is associated with transient reduction in dengue infection risk among dengue-naïve children

Dengvaxia ® induces antibody responses in dengue virus (DENV)-naïve children, but the durability of these responses and their impact on subsequent wild-type (WT) DENV infection remain unclear. Although previous studies have primarily evaluated vaccine efficacy against dengue disease, the impact of Dengvaxia ® on...

M. Abad-Fernández, J. Daag, L. D. Hein et al. · 0 citations
Open access Aug 2026

A Zika Virus Vaccine with E Protein Fusion Loop Mutations Protects via CD8+ T Cells

There are currently no effective vaccines against Zika virus (ZIKV). Candidate vaccines target the ZIKV envelope (E) protein, the major target of anti-ZIKV neutralizing antibodies (nAbs). Here, we utilized DNA and RNA platforms to compare virus-like particle vaccines with premembrane (prM) and E expressed either in the...

Kantinan Chuensirikulchai, Qin-Hui Li, Hsueh-Han Lu et al. · 0 citations
Open access Aug 2026

Severity-associated changes in ICOS, CD27, CD127 and CLA expression and expansion of virus-specific T Cells in acute dengue.

BACKGROUND Currently the role of dengue virus (DENV) specific T cell responses in disease pathogenesis and protection are not well understood, including potential differences in those who have obesity. We sought to investigate the functionality and phenotype of T cells in patients with acute dengue fever (DF) or dengue...

H. Kuruppu, M. De Silva, Chathumini Dissanayake et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.